About Trabectedin
            
            Class: | Antineoplastic agent, Alkylating agent  
Use: | Treatment of soft tissue sarcoma in adults after prior chemotherapy; treatment of relapsed ovarian cancer in combination with pegylated liposomal doxorubicin  
Adult dose: | 1.5 mg/m² administered as an intravenous infusion over 24 hours every 21 days  
Pediatric dose: | Safety and efficacy not established in pediatric patients  
Side effects: | Nausea, vomiting, fatigue, liver enzyme elevation, myelosuppression, peripheral edema, and incr
         
        
            
                
                
                    
                        Drug Class
                    
                    Antineoplastic agent, Alkylating agent
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of soft tissue sarcoma in adults after prior chemotherapy; treatment of relapsed ovarian cancer in combination with pegylated liposomal doxorubicin
                 
                
                
                    
                        Storage Requirements
                    
                    Store at 2°C to 8°C (36°F to 46°F); protect from light; do not freeze
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Johnson & Johnson, U.S.A
                    
                    
                    Package Size
                    1 Vial
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 12039.10
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        1.5 mg/m² administered as an intravenous infusion over 24 hours every 21 days
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established in pediatric patients
                    
                 
                
                
                    
                        Side Effects
                    
                    Nausea, vomiting, fatigue, liver enzyme elevation, myelosuppression, peripheral edema, and increased risk of infection
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to trabectedin or any component of the formulation; severe hepatic impairment; pregnancy and breastfeeding
         
        
        
            
                Important Warnings
            
            Risk of severe liver toxicity; monitor liver function tests; risk of myelosuppression; caution in patients with pre-existing liver disease; potential for teratogenic effects; avoid use in pregnancy and breastfeeding
         
        
        
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.